Prices are updated after-hours
Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2022 - 01 - 05    source : Www.sutrobio.com    save search
Sutro Biopharma Announces Interim Data from Dose-Expansion Cohort of STRO-002 Phase 1 Study for Patients with Advanced Ovarian Cancer
Published: 2022-01-05 (Crawled : 10:00) - sutrobio.com
STRO | $3.635 -3.58% -3.71% 520K twitter stocktwits trandingview |
Health Technology
 | | O: -20.18% H: 0.0% C: -9.63%
stro-002 biopharma expansion ovarian cancer phase 1 cancer
2022 KOL Discussion of STRO-002 Phase 1 Interim Dose Expansion Data – Presentation
Published: 2022-01-05 (Crawled : 10:00) - sutrobio.com
STRO | $3.635 -3.58% -3.71% 520K twitter stocktwits trandingview |
Health Technology
 | | O: -20.18% H: 0.0% C: -9.63%
stro-002 expansion presentation phase 1 phase 2 phase 3
Gainers vs Losers
67% 33%

Top 10 Gainers
Your saved searches
Save your searches and get alerts when important news are released.